Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Newcomers To White House, FDA Augur Up-Regulation: Top Stories Of 2009

This article was originally published in The Rose Sheet

Executive Summary

The prospect of heightened regulation under the Obama administration and a reorganized FDA - in an environment characterized by high pressure from public safety groups - commanded the attention of personal-care interests in 2009

You may also be interested in...



Council Celebrating Industry's Contribution To Economy At 2010 Meeting

The Personal Care Products Council will continue to focus on cosmetics legislation in 2010 while promoting the industry's positive impact on the U.S. economy and working to help members stay competitive in a trying market

Council Celebrating Industry's Contribution To Economy At 2010 Meeting

The Personal Care Products Council will continue to focus on cosmetics legislation in 2010 while promoting the industry's positive impact on the U.S. economy and working to help members stay competitive in a trying market

Study Finding Musks In Newborns Warrants Updated Fragrance Labeling Law - CSC

The Campaign for Safe Cosmetics says a new study finding fragrance chemicals in infant umbilical cord blood supports closing a "loophole" in federal packaging law that allows marketers to omit fragrance ingredients from labels

Related Content

UsernamePublicRestriction

Register

PS142249

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel